Jason Wittes

Stock Analyst at Roth Capital

(2.61)
# 1,812
Out of 5,182 analysts
58
Total ratings
48.08%
Success rate
3.77%
Average return

Stocks Rated by Jason Wittes

ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $7.94
Upside: +403.78%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405$456
Current: $321.43
Upside: +41.87%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15$16
Current: $2.24
Upside: +614.29%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $11.92
Upside: +84.56%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60$72
Current: $84.49
Upside: -14.78%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.49
Upside: +144.99%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100$115
Current: $90.74
Upside: +26.74%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $5.26
Upside: +109.13%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $112.40
Upside: -11.03%
Reiterates: Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Initiates: Buy
Price Target: $9
Current: $0.43
Upside: +1,978.04%
Initiates: Buy
Price Target: $75
Current: $23.40
Upside: +220.51%
Initiates: Buy
Price Target: $22
Current: $9.35
Upside: +135.29%
Initiates: Neutral
Price Target: $120
Current: $82.80
Upside: +44.93%
Initiates: Buy
Price Target: $206
Current: $178.51
Upside: +15.40%
Reinstates: Buy
Price Target: $145
Current: $196.51
Upside: -26.21%
Initiates: Buy
Price Target: $7.5
Current: $16.10
Upside: -53.42%
Initiates: Buy
Price Target: $200
Current: $12.12
Upside: +1,550.17%
Initiates: Buy
Price Target: $26
Current: $34.58
Upside: -24.81%